Outlook Wealth Advisors, LLC Pfizer Inc Transaction History

Outlook Wealth Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $184,451 - $240,781	4,418 New	4,418 $226,000
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $7,351 - $8,716	-158 Reduced 3.49%	4,367 $229,000
Q1 2022 Jul 28, 2022	BUY	$45.75 - $56.69 $207,018 - $256,522	4,525 New	4,525 $234,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $204,136 - $252,950	-4,462 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $18,139 - $26,888	-439 Reduced 8.96%	4,462 $263,000
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $8,949 - $11,495	-228 Reduced 4.45%	4,901 $211,000
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $184,182 - $208,647	5,129 New	5,129 $201,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $235,401 - $265,485	-7,029 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $45,385 - $57,711	-1,356 Reduced 16.17%	7,029 $259,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $29,622 - $34,754	933 Added 12.52%	8,385 $308,000
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $35,360 - $42,897	-1,174 Reduced 13.61%	7,452 $244,000
Q1 2020 Apr 16, 2020	SELL	$27.03 - $38.62 $54,141 - $77,355	-2,003 Reduced 18.84%	8,626 $282,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $16,855 - $19,128	-512 Reduced 4.6%	10,629 $416,000
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $207,351 - $268,873	6,382 Added 134.1%	11,141 $400,000
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $175,987 - $197,593	4,759 New	4,759 $206,000
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $46,987 - $51,623	-1,253 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $48,202 - $54,956	1,253 New	1,253 $547,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Outlook Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Outlook Wealth Advisors, LLC with notifications on news.